| Index | — | P/E | 19.04 | EPS (ttm) | 0.24 | Insider Own | 0.20% | Shs Outstand | 1.29B | Perf Week | -4.59% |
| Market Cap | 5.90B | Forward P/E | 10.52 | EPS next Y | 0.43 | Insider Trans | 0.00% | Shs Float | 723.39M | Perf Month | -9.33% |
| Enterprise Value | 8.53B | PEG | 2.36 | EPS next Q | 0.11 | Short Float | 0.53% | Perf Quarter | -11.26% | ||
| Income | 305.00M | P/S | 0.76 | EPS this Y | 13.37% | Short Ratio | 3.25 | Perf Half Y | -17.36% | ||
| Sales | 7.71B | P/B | 0.92 | EPS next Y | 6.76% | ROA | 2.32% | Short Interest | 3.85M | Perf YTD | -19.96% |
| Book/sh | 4.99 | P/C | 8.91 | EPS next 5Y | 8.06% | ROE | 5.02% | 52W High | 6.97 -35.65% | Perf Year | -29.80% |
| Cash/sh | 0.51 | P/FCF | 20.27 | EPS past 3/5Y | -51.73% 57.28% | ROIC | 5.04% | 52W Low | 4.49 0.00% | Perf 3Y | -5.19% |
| Dividend Est. | 0.23 (5.18%) | EV/EBITDA | 5.85 | Sales past 3/5Y | -10.61% 7.24% | Gross Margin | 30.63% | Volatility | 2.40% 2.00% | Perf 5Y | -47.77% |
| Dividend TTM | 0.21 (4.60%) | EV/Sales | 1.11 | EPS Y/Y TTM | -17.77% | Oper. Margin | 10.87% | ATR (14) | 0.12 | Perf 10Y | 22.85% |
| Dividend Ex-Date | Sep 02, 2026 | Quick Ratio | 0.94 | Sales Y/Y TTM | 10.92% | Profit Margin | 3.96% | RSI (14) | 29.89 | Recom | 3.00 |
| Dividend Gr. 3/5Y | -42.29% 13.45% | Current Ratio | 1.58 | EPS Q/Q | 33.33% | SMA20 | -5.91% | Beta | 1.00 | Target Price | 5.98 |
| Payout | 82.59% | Debt/Eq | 0.51 | Sales Q/Q | 16.54% | SMA50 | -12.70% | Rel Volume | 1.66 | Prev Close | 4.57 |
| Employees | 13,007 | LT Debt/Eq | 0.41 | Earnings | Nov 11 | SMA200 | -15.19% | Avg Volume | 1.40M | Price | 4.49 |
| IPO Date | Mar 22, 2005 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 13.55% 6.09% | Net Debt/EBITDA | 1.81 | Volume | 2,327,728 | Change | -1.86% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-16-26 | Reiterated | Morgan Stanley | Equal Weight | $5.75 → $5.45 |
| Aug-10-26 | Reiterated | Morgan Stanley | Equal Weight | $5.60 → $5.75 |
| Jul-27-26 | Reiterated | Barclays | Equal Weight | $7.00 → $6.00 |
| May-28-26 | Reiterated | Morgan Stanley | Equal Weight | $5.40 → $5.80 |
| May-20-26 | Reiterated | BMO Capital | Market Perform | $11 → $6.50 |
| May-18-26 | Reiterated | Barclays | Equal Weight | $7.00 |
| Jan-14-26 | Reiterated | Morgan Stanley | Equal Weight | $5.80 → $6.15 |
| Jan-21-25 | Upgrade | Barclays | Underweight → Equal Weight | |
| May-16-24 | Reiterated | Jefferies | $5.00 | |
| Apr-08-24 | Reiterated | Morgan Stanley | Equal Weight | $8.50 → $5.20 |
ICL Group Ltd, a global enterprise specializing in the production of minerals and chemicals, conducts its operations through four distinct business units. The company, which originated as Israel Chemicals Ltd and adopted its current name in May 2020, was founded in 1968 and maintains its headquarters in Tel Aviv, Israel. The Industrial Products segment is responsible for extracting bromine from a byproduct solution generated during potash production, subsequently manufacturing bromine-based compounds. It also produces various grades of potash, salt, magnesium chloride, and magnesia products, alongside the creation and distribution of phosphorus-based flame retardants and other phosphorus derivatives. Within its Potash division, ICL sources potash from the Dead Sea, while simultaneously engaging in the mining and production of potash and salt. This segment is also a producer of Polysulphate, and it manufactures and markets magnesium and its alloys, along with associated by-products like chlorine and sylvinite. Additionally, it sells salt. The Phosphate Solutions segment converts foundational phosphate commodities into specialized products. It manufactures and distributes phosphate-based fertilizers, sulphuric acid, and green phosphoric acid. This unit also produces thermal phosphoric acid for a diverse array of industrial uses, spanning sectors such as oral hygiene, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. Moreover, it develops and produces functional food ingredients and phosphate additives for application in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets, as well as manufacturing milk and whey proteins for the broader food ingredients industry. Finally, the Innovative Ag Solutions (IAS) segment focuses on the development, manufacturing, marketing, and sale of fertilizers primarily composed of nitrogen, potash, and phosphate. This includes a spectrum of products such as water-soluble specialty, liquid, soluble, and controlled-release fertilizers. ICL Group's diverse product portfolio reaches global markets through an established network of marketing firms, agents, and distributors.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,712 | 7,153 | 6,841 | 7,536 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 5,350 | 4,967 | 4,585 | 4,865 | — | — | — | — | — | |
| Gross Profit | 2,362 | 2,186 | 2,256 | 2,671 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,482 | 1,413 | 1,371 | 1,353 | — | — | — | — | — | |
| Research and Development | 62 | 70 | 69 | 71 | — | — | — | — | — | |
| Other Operating Expense | -13 | 0 | 41 | 106 | — | — | — | — | — | |
| Operating Income | 831 | 703 | 775 | 1,141 | — | — | — | — | — | |
| Interest Expense | 331 | 298 | 151 | 160 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 42 | 36 | 12 | -7 | — | — | — | — | — | |
| Net Income Before Taxes | 542 | 441 | 636 | 974 | — | — | — | — | — | |
| Income Taxes | 184 | 161 | 172 | 287 | — | — | — | — | — | |
| Consolidated Net Income | 305 | 226 | 407 | 647 | — | — | — | — | — | |
| Net Income From Continuing Operations | 358 | 280 | 464 | 687 | — | — | — | — | — | |
| Net Income | 305 | 226 | 407 | 647 | — | — | — | — | — | |
| EPS (Recurring) | 0.24 | 0.18 | 0.32 | 0.50 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.24 | 0.18 | 0.32 | 0.50 | — | — | — | — | — | |
| EPS (Diluted) | 0.24 | 0.18 | 0.32 | 0.50 | — | — | — | — | — | |
| EBITDA | 1,459 | 1,354 | 1,378 | 1,670 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.69 | 31.72 | 15.44 | 10.02 | — | — | — | — | — | |
| Price To Sales Ratio | 0.75 | 1.03 | 0.93 | 0.86 | — | — | — | — | — | |
| Gross Margin | 30.63 | 30.56 | 32.98 | 35.44 | — | — | — | — | — | |
| Operating Margin | 10.78 | 9.83 | 11.33 | 15.14 | — | — | — | — | — | |
| Net Margin | 3.95 | 3.16 | 5.95 | 8.59 | — | — | — | — | — | |
| Shares Outstanding | 1,291 | 1,291 | 1,290 | 1,289 | — | — | — | — | — | |
| Market Capitalization | 5,790 | 7,372 | 6,373 | 6,458 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |